Corrigendum: Clinical Improvement Following Stroke Promptly Reverses Post-stroke Cellular Immune Alterations

Corrigendum: Clinical Improvement Following Stroke Promptly Reverses Post-stroke Cellular Immune Alterations

Bibliographic Details
Main Authors:	Antje Vogelgesang, Carl Witt, Christin Heuer, Juliane Schulze, Juliane Gellrich, Bettina von Sarnowski, Sönke Langner, Alexander Dressel, Johanna Ruhnau
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-09-01
Series:	Frontiers in Neurology
Subjects:	stroke immunosuppression tissue plasminogen activator HMGB-1 miRNA
Online Access:	https://www.frontiersin.org/article/10.3389/fneur.2020.593366/full

Similar Items

Clinical Improvement Following Stroke Promptly Reverses Post-stroke Cellular Immune Alterations
by: Antje Vogelgesang, et al.
Published: (2019-05-01)

Thrombosis, Neuroinflammation, and Poststroke Infection: The Multifaceted Role of Neutrophils in Stroke
by: Johanna Ruhnau, et al.
Published: (2017-01-01)

Immune Alterations Following Neurological Disorders: A Comparison of Stroke and Seizures
by: Johanna Ruhnau, et al.
Published: (2020-06-01)

Stroke-Induced Modulation of Myeloid-Derived Suppressor Cells (MDSCs) and IL-10-Producing Regulatory Monocytes
by: Lennart Achmus, et al.
Published: (2020-11-01)

Reduced Numbers and Impaired Function of Regulatory T Cells in Peripheral Blood of Ischemic Stroke Patients
by: Johanna Ruhnau, et al.
Published: (2016-01-01)

t-PA Suppresses the Immune Response and Aggravates Neurological Deficit in a Murine Model of Ischemic Stroke
by: Dominik F. Draxler, et al.
Published: (2019-03-01)

Cell permeable HMGB1-binding heptamer peptide ameliorates neurovascular complications associated with thrombolytic therapy in rats with transient ischemic stroke
by: Miaodan Li, et al.
Published: (2018-08-01)

Ischaemic stroke and the recanalization drug tissue plasminogen activator interfere with antibacterial phagocyte function
by: Antje Vogelgesang, et al.
Published: (2017-07-01)

The Regulatory Role of High-Mobility Group Protein 1 in Sepsis-Related Immunity
by: Li Li, et al.
Published: (2021-01-01)

Tanshinone IIA attenuates sepsis-induced immunosuppression and improves survival rate in a mice peritonitis model
by: Min Gao, et al.
Published: (2019-04-01)

Thrombolysis in Stroke Patients; Problems and Limitations
by: Kavian Ghandehari,, et al.
Published: (2010-06-01)

Barriers to Stroke Thrombolysis
by: Ajay Panwar, et al.
Published: (2017-12-01)

Intravenous Thrombolytic Therapy in Acute Ischemic Stroke
by: Semai Bek, et al.
Published: (2009-12-01)

Time to Develop Therapeutic Antibodies Against Harmless Proteins Colluding with Sepsis Mediators?
by: Li J, et al.
Published: (2020-10-01)

Treatment analysis of intravenous thrombolysis in patients with mild ischemic stroke
by: Zhao⁃hui SONG, et al.
Published: (2019-12-01)

Treatment for ischemic stroke: From thrombolysis to thrombectomy and remaining challenges
by: Tiandong Leng, et al.
Published: (2019-01-01)

Functional status of peripheral blood T-cells in ischemic stroke patients.
by: Antje Vogelgesang, et al.
Published: (2010-01-01)

Role of HMGB1 in the Interplay between NETosis and Thrombosis in Ischemic Stroke: A Review
by: Seung-Woo Kim, et al.
Published: (2020-07-01)

The Outcome of Treatment with Recombinant Tissue Plasminogen Activator in Acute Ischemic Stroke
by: Alia Saberi, et al.
Published: (2021-07-01)

Multidisciplinary Approach to Decrease In-Hospital Delay for Stroke Thrombolysis
by: Sang-Beom Jeon, et al.
Published: (2017-05-01)

MiRNAs Regulating Insulin Sensitivity Are Dysregulated in Polycystic Ovary Syndrome (PCOS) Ovaries and Are Associated With Markers of Inflammation and Insulin Sensitivity
by: Francesca Cirillo, et al.
Published: (2019-12-01)

Efficacy and safety of thrombolysis in treatment of minor stroke
by: Guang⁃hua LI, et al.
Published: (2020-10-01)

Symptom-to-needle Times in Acute Ischemic Stroke and Its Prehospital Related Factors
by: Mozaffar Hosseininezhad, et al.
Published: (2020-10-01)

Unruptured Cerebral Aneurysm Detected after Intravenous Tissue Plasminogen Activator for Stroke
by: Yukihiro Yoneda, et al.
Published: (2009-06-01)

An observation study on the curative effect of butylphthalide sodium chloride combined with urokinase in the treatment of acute ischemic stroke
by: Hui-yan NIU, et al.
Published: (2014-09-01)

Intravenous Thrombolysis for Embolic Stroke due to Cardiac Myxoma
by: Mu-Chien Sun, et al.
Published: (2011-01-01)

Evaluation of Patients with Ischemic Stroke Receiving iv t-PA in the Emergency Department
by: Omer Salt, et al.
Published: (2018-06-01)

Association between different acute stroke therapies and development of post stroke seizures
by: Jillian Naylor, et al.
Published: (2018-05-01)

Effect of Tissue Plasminogen Activator Dose and Interval on Stroke Severity
by: Nedelman, Cassandra B., et al.
Published: (2014)

Clinical Experience of Intra-Arterial Therapy in Patients with Acute Ischemic Stroke from a Single Institute
by: So Young Park, et al.
Published: (2016-11-01)

Hemorrhagic complications of thrombolytic therapy eight years of experience from Banjaluka’s University hospital: Stroke unit
by: Vujković Zoran, et al.
Published: (2016-01-01)

Stroke-induced immunosuppression: implications for the prevention and prediction of post-stroke infections
by: Júlia Faura, et al.
Published: (2021-06-01)

Intravenous thrombolytic for 16 patients with stroke warning syndrome
by: Jing⁃yu PENG
Published: (2020-05-01)

Actively developing intravenous thrombolysis for acute ischemic stroke
by: Jin-huan WANG
Published: (2013-04-01)

Recent Advances in Tissue plasminogen activator-based nanothrombolysis for ischemic stroke
by: Huang Dongdong, et al.
Published: (2019-09-01)

Comparing the Quality of Life in Patients with Stroke Under the Treatment with and Without Recombinant Tissue Plasminogen Activator
by: Zahra Goudarzi, et al.
Published: (2019-06-01)

Effectiveness of alteplase in the very elderly after acute ischemic stroke
by: Yayan J
Published: (2013-07-01)

tPA Helpers in the Treatment of Acute Ischemic Stroke: Are They Ready for Clinical Use?
by: Jong S. Kim
Published: (2019-05-01)

Acute Ischemic Stroke in Term Pregnancy Treated with Recombinant Tissue Plasminogen Activator
by: Sanjith Aaron, et al.
Published: (2020-12-01)

Effectiveness of Stroke Training Provided to Istanbul Medical Staff
by: Semih Korkut, et al.
Published: (2021-01-01)